DenovAI developed a foundational technology platform that designs proteins de novo. We design next generation therapeutics including high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters - all tailored to bind to their specific targets.
id: scarlet-lynx-lava
Nipah Virus Glycoprotein G
0.83
77.07
--
13.5 kDa
125
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
Private
Private Protein
This protein is not publicly visible
